Erasca, Inc. (ERAS)
12.46
+0.96
(+8.35%)
USD |
NASDAQ |
May 27, 16:00
12.46
0.00 (0.00%)
After-Hours: 16:35
Erasca Cash from Investing (Quarterly) : -243.83M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 172.62M |
| Tango Therapeutics, Inc. | 9.635M |
| Praxis Precision Medicines, Inc. | -344.28M |
| Scholar Rock Holding Corp. | -5.335M |
| Kymera Therapeutics, Inc. | -142.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.38M |
| Cash from Financing (Quarterly) | 244.66M |
| Free Cash Flow | -91.36M |
| Free Cash Flow Per Share (Quarterly) | -0.0901 |
| Free Cash Flow to Equity (Quarterly) | -26.23M |
| Free Cash Flow to Firm (Quarterly) | -27.42M |
| Free Cash Flow Yield | -2.54% |